Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI)

CAPS Rating:

A biopharmaceutical company focused on the development & commercialization of late-stage, targeted therapeutic clinical products in the areas of respiratory disease &, through its publicly-traded subsidiary, Biovest International Inc., oncology.